The Neuromodulation devices market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Surging Demand for Deep Brain Stimulation (DBS) in Neuromodulation
The demand for deep brain stimulation (DBS) in neuromodulation has experienced a notable surge, driven by factors such as expanded applications, technological advancements, positive clinical outcomes, progress in neurological research, and increased awareness among patients and healthcare providers. This surge reflects the growing acceptance of DBS as an effective therapeutic intervention for various neurological disorders. Ongoing developments in the field of neuromodulation continue to contribute to the increased demand for DBS, showcasing its potential to address diverse medical conditions and improve patient outcomes.
Complications Associated with Usage of Neuromodulation Devices
The use of neuromodulation devices, while offering therapeutic benefits, is not without potential complications. Complications associated with these devices can include infection at the implantation site, hardware malfunctions, lead migration or breakage, and adverse reactions to electrical stimulation. Additionally, patients may experience side effects such as tingling, pain, or muscle contractions. Proper patient selection, precise surgical placement, and ongoing monitoring are crucial to minimizing risks. Despite the efficacy of neuromodulation, the potential for complications underscores the importance of careful patient evaluation, thorough preoperative planning, and vigilant postoperative management to ensure the safe and effective use of these devices in managing various neurological conditions.
What Questions Should You Ask before Buying a Market Research Report?
- How is the Neuromodulation devices market evolving?
- What is driving and restraining the neuromodulation devices market?
- How will each neuromodulation devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each Neuromodulation devices submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading neuromodulation devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the neuromodulation devices projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of neuromodulation devices projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the neuromodulation devices market?
- Where is the neuromodulation devices market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Neuromodulation devices market today, and over the next 10 years:
- Our 251-page report provides 96 tables and 133 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Neuromodulation devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Neuromodulation devices prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Product
- Deep Brain Stimulator
- Gastric Electric Stimulator
- Spinal Cord Stimulator
- Sacral Nerve Stimulator
- Vagus Nerve Stimulator
- Transcutaneous Electrical Nerve Stimulator
- Others
By Application
- Pain Management
- Epilepsy
- Essential Tremor
- Urinary and Fecal Incontinence
- Depression
- Dystonia
- Gastroparesis
- Parkinson’s Disease
- Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets
North America
Europe
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Neuromodulation devices market, 2024 to 2034, with a focus on this segment of these companies’ operations.
Leading companies profiled in the report
- Abbott
- Boston Scientific Corporation
- electroCore, Inc.
- Helbling Holding AG
- Innovative Health Solutions
- LivaNova PLC
- Medtronic
- MicroTransponder Inc.
- Neuronetics Inc.
- Parasym
- Synapse Biomedical Inc.
- tVNS Technologies GmbH
Overall world revenue for Neuromodulation devices market, 2024 to 2034 in terms of value the market will surpass US$10.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Neuromodulation devices market, 2024 to 2034 report help you?
In summary, our 250+ page report provides you with the following knowledge:
- Revenue forecasts to 2034 for Neuromodulation devices market, 2024 to 2034 Market, with forecasts for product, application and route of administration, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 21 key national markets – See forecasts for the Neuromodulation devices market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market – including company profiles for 12 of the major companies involved in the Neuromodulation devices market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Neuromodulation devices market 2024 to 2034, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Neuromodulation Devices Market Report 2024-2034: Forecasts by Product (Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation (TENS)), by Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Faecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Neuromodulation Devices Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Demand for Deep Brain Stimulator Neuromodulation Devices in Pharmaceutical and Biotechnology Industry
3.2.1.2 Rising Prevalence of Neurological Disorders and Nerve Injuries
3.2.1.3 Growing Preference Among Patients for Non-invasive Treatments
3.2.1.4 Expanded Therapeutic Applications of Neuromodulation Devices
3.2.1.5 Technological Advancements in Neuromodulation Devices
3.2.2 Market Restraining Factors
3.2.2.1 Complications Associated with Usage of Neuromodulation Devices
3.2.2.2 High Cost of Neuromodulation Devices
3.2.2.3 Stringent Regulatory Framework and a Thorough Approval Process
3.2.2.4 Preference for Drug Therapies over Neuromodulation Products
3.2.2.5 Product Recalls in the Neuromodulation Devices
3.2.2.6 Lack of Skilled Healthcare Practitioners
3.2.3 Market Opportunities
3.2.3.1 Rising Demand for Minimally Invasive Surgeries in Developed Countries
3.2.3.2 Increasing Number of Elderly Patients with Neurological Disorders
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Neuromodulation Devices Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Neuromodulation Devices Market Size Estimation and Forecast by Product
4.4 Deep Brain Stimulator
4.4.1 Market Size by Region, 2024-2034 (US$ Million)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Gastric Electric Stimulator
4.5.1 Market Size by Region, 2024-2034 (US$ Million)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Spinal Cord Stimulator
4.6.1 Market Size by Region, 2024-2034 (US$ Million)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Sacral Nerve Stimulator
4.7.1 Market Size by Region, 2024-2034 (US$ Million)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Vagus Nerve Stimulator
4.8.1 Market Size by Region, 2024-2034 (US$ Million)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Transcutaneous Electrical Nerve Stimulator
4.9.1 Market Size by Region, 2024-2034 (US$ Million)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Others
4.10.1 Market Size by Region, 2024-2034 (US$ Million)
4.10.2 Market Share by Region, 2024 & 2034 (%)
5 Neuromodulation Devices Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Neuromodulation Devices Market Size Estimation and Forecast by Application
5.4 Pain Management
5.4.1 Market Size by Region, 2024-2034 (US$ Million)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Epilepsy
5.5.1 Market Size by Region, 2024-2034 (US$ Million)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Essential Tremor
5.6.1 Market Size by Region, 2024-2034 (US$ Million)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 Urinary and Fecal Incontinence
5.7.1 Market Size by Region, 2024-2034 (US$ Million)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Depression
5.8.1 Market Size by Region, 2024-2034 (US$ Million)
5.8.2 Market Share by Region, 2024 & 2034 (%)
5.9 Dystonia
5.9.1 Market Size by Region, 2024-2034 (US$ Million)
5.9.2 Market Share by Region, 2024 & 2034 (%)
5.10 Gastroparesis
5.10.1 Market Size by Region, 2024-2034 (US$ Million)
5.10.2 Market Share by Region, 2024 & 2034 (%)
5.11 Parkinson’s Disease
5.11.1 Market Size by Region, 2024-2034 (US$ Million)
5.11.2 Market Share by Region, 2024 & 2034 (%)
5.12 Others
5.12.1 Market Size by Region, 2024-2034 (US$ Million)
5.12.2 Market Share by Region, 2024 & 2034 (%)
6 Neuromodulation Devices Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Neuromodulation Devices Market Analysis
7.1 Key Findings
7.2 North America Neuromodulation Devices Market Attractiveness Index
7.3 North America Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
7.4 North America Neuromodulation Devices Market Size Estimation and Forecast by Country
7.5 North America Neuromodulation Devices Market Size Estimation and Forecast by Product
7.6 North America Neuromodulation Devices Market Size Estimation and Forecast by Application
7.7 U.S. Neuromodulation Devices Market Analysis
7.8 Canada Neuromodulation Devices Market Analysis
8 Europe Neuromodulation Devices Market Analysis
8.1 Key Findings
8.2 Europe Neuromodulation Devices Market Attractiveness Index
8.3 Europe Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
8.4 Europe Neuromodulation Devices Market Size Estimation and Forecast by Country
8.5 Europe Neuromodulation Devices Market Size Estimation and Forecast by Product
8.6 Europe Neuromodulation Devices Market Size Estimation and Forecast by Application
8.7 Germany Neuromodulation Devices Market Analysis
8.8 France Neuromodulation Devices Market Analysis
8.9 UK Neuromodulation Devices Market Analysis
8.10 Italy Neuromodulation Devices Market Analysis
8.11 Spain Neuromodulation Devices Market Analysis
8.12 Russia Neuromodulation Devices Market Analysis
8.13 Rest of Europe Neuromodulation Devices Market Analysis
9 Asia Pacific Neuromodulation Devices Market Analysis
9.1 Key Findings
9.2 Asia Pacific Neuromodulation Devices Market Attractiveness Index
9.3 Asia Pacific Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
9.4 Asia Pacific Neuromodulation Devices Market Size Estimation and Forecast by Country
9.5 Asia Pacific Neuromodulation Devices Market Size Estimation and Forecast by Product
9.6 Asia Pacific Neuromodulation Devices Market Size Estimation and Forecast by Application
9.7 Japan Neuromodulation Devices Market Analysis
9.8 China Neuromodulation Devices Market Analysis
9.9 India Neuromodulation Devices Market Analysis
9.10 Australia Neuromodulation Devices Market Analysis
9.11 South Korea Neuromodulation Devices Market Analysis
9.12 Rest of Asia Pacific Neuromodulation Devices Market Analysis
10 Latin America Neuromodulation Devices Market Analysis
10.1 Key Findings
10.2 Latin America Neuromodulation Devices Market Attractiveness Index
10.3 Latin America Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
10.4 Latin America Neuromodulation Devices Market Size Estimation and Forecast by Country
10.5 Latin America Neuromodulation Devices Market Size Estimation and Forecast by Product
10.6 Latin America Neuromodulation Devices Market Size Estimation and Forecast by Application
10.7 Brazil Neuromodulation Devices Market Analysis
10.8 Mexico Neuromodulation Devices Market Analysis
10.9 Rest of Latin America Neuromodulation Devices Market Analysis
11 MEA Neuromodulation Devices Market Analysis
11.1 Key Findings
11.2 MEA Neuromodulation Devices Market Attractiveness Index
11.3 MEA Neuromodulation Devices Market by Country, 2024, 2029 & 2034 (US$ Million)
11.4 MEA Neuromodulation Devices Market Size Estimation and Forecast by Country
11.5 MEA Neuromodulation Devices Market Size Estimation and Forecast by Product
11.6 MEA Neuromodulation Devices Market Size Estimation and Forecast by Application
11.7 GCC Neuromodulation Devices Market Analysis
11.8 South Africa Neuromodulation Devices Market Analysis
11.9 Rest of MEA Neuromodulation Devices Market Analysis
12 Company Profiles
12.1 Competitive Landscape, 2022
12.2 Strategic Outlook
12.3 Abbott
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Net Revenue, 2017-2022
12.3.3.2 R&D, 2017-2022
12.3.3.3 Regional Market Shares, 2022
12.3.4 Product Benchmarking
12.3.5 Strategic Outlook
12.4 Boston Scientific Corporation
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2017-2022
12.4.3.2 R&D, 2017-2022
12.4.3.3 Regional Market Shares, 2022
12.4.4 Product Benchmarking
12.4.5 Strategic Outlook
12.5 electroCore, Inc.
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2017-2022
12.5.3.2 R&D, 2017-2022
12.5.3.3 Regional Market Shares, 2022
12.5.4 Product Benchmarking
12.5.5 Strategic Outlook
12.6 Helbling Holding AG
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2017-2022
12.6.4 Product Benchmarking
12.6.5 Strategic Outlook
12.7 Innovative Health Solutions
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Product Benchmarking
12.8 LivaNova PLC
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2017-2022
12.8.3.2 R&D, 2017-2022
12.8.3.3 Regional Market Shares, 2022
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Medtronic
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Financial Analysis
12.9.3.1 Net Revenue, 2017-2022
12.9.3.2 R&D, 2017-2022
12.9.3.3 Regional Market Shares, 2022
12.9.4 Product Benchmarking
12.9.5 Strategic Outlook
12.10 MicroTransponder Inc.
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Product Benchmarking
12.10.4 Strategic Outlook
12.11 Neuronetics Inc.
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2022
12.11.3.2 R&D, 2017-2022
12.11.3.3 Regional Market Shares, 2022
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Parasym
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Product Benchmarking
12.12.4 Strategic Outlook
12.13 Synapse Biomedical Inc
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Product Benchmarking
12.13.4 Strategic Outlook
12.14 tVNS Technologies GmbH
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Product Benchmarking
12.14.4 Strategic Outlook
13 Conclusion and Recommendations
13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players
List of Tables
Table 1 Neuromodulation Devices Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
Table 2 Neuromodulation Devices Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Neuromodulation Devices Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Neuromodulation Devices Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Neuromodulation Devices Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 7 Deep Brain Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 8 Gastric Electric Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 9 Spinal Cord Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 10 Sacral Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 11 Vagus Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 12 Transcutaneous Electrical Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 13 Others Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 14 Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 15 Pain Management Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 16 Epilepsy Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 17 Essential Tremor Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 18 Urinary and Fecal Incontinence Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 19 Depression Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 20 Dystonia Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 21 Gastroparesis Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 22 Parkinson’s Disease Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 23 Others Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 24 Neuromodulation Devices Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 25 North America Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 26 North America Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 27 North America Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 28 U.S. Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 29 Canada Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 30 Europe Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 31 Europe Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 32 Europe Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 33 Germany Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 34 France Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 35 UK Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 36 Italy Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 37 Spain Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 38 Russia Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 39 Rest of Europe Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 40 Asia Pacific Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 41 Asia Pacific Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 42 Asia Pacific Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 43 Japan Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 44 China Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 45 India Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 46 Australia Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 47 South Korea Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 48 Rest of Asia Pacific Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 49 Latin America Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 50 Latin America Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 51 Latin America Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 52 Brazil Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 53 Mexico Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 54 Rest of Latin America Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 55 MEA Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 56 MEA Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 57 MEA Neuromodulation Devices Market Application, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 58 GCC Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 59 South Africa Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 60 Rest of MEA Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR %)
Table 61 Strategic Outlook
Table 62 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Abbott: Product Benchmarking
Table 64 Abbott.: Strategic Outlook
Table 65 Boston Scientific Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 Boston Scientific Corporation, Inc.: Product Benchmarking
Table 67 Boston Scientific Corporation, Inc.: Strategic Outlook
Table 68 electroCore, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 electroCore, Inc.: Product Benchmarking
Table 70 electroCore, Inc.: Strategic Outlook
Table 71 Helbling Holding AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Helbling Holding AG: Product Benchmarking
Table 73 Helbling Holding AG: Strategic Outlook
Table 74 Innovative Health Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Innovative Health Solutions: Product Benchmarking
Table 76 LivaNova PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 LivaNova PLC: Product Benchmarking
Table 78 LivaNova PLC: Strategic Outlook
Table 79 Medtronic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Medtronic: Product Benchmarking
Table 81 Medtronic: Strategic Outlook
Table 82 MicroTransponder Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 MicroTransponder Inc.: Product Benchmarking
Table 84 MicroTransponder Inc..: Strategic Outlook
Table 85 Neuronetics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Neuronetics Inc.: Product Benchmarking
Table 87 Neuronetics Inc.: Strategic Outlook
Table 88 Parasym: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Parasym: Product Benchmarking
Table 90 Parasym: Strategic Outlook
Table 91 Synapse Biomedical Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Synapse Biomedical Inc.: Product Benchmarking
Table 93 Synapse Biomedical Inc.: Strategic Outlook
Table 94 tVNS Technologies GmbH.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 tVNS Technologies GmbH.: Product Benchmarking
Table 96 tVNS Technologies GmbH.: Strategic Outlook
List of Figures
Figure 1 Neuromodulation Devices Market Segmentation
Figure 2 Neuromodulation Devices Market by Product: Market Attractiveness Index
Figure 3 Neuromodulation Devices Market by Application: Market Attractiveness Index
Figure 4 Neuromodulation Devices Market Attractiveness Index by Region
Figure 5 Neuromodulation Devices Market: Market Dynamics
Figure 6 Neuromodulation Devices Market by Region, 2024-2034 (US$ Million, AGR %): “V” Shaped Recovery
Figure 7 Neuromodulation Devices Market by Region, 2024-2034 (US$ Million, AGR %): “U” Shaped Recovery
Figure 8 Neuromodulation Devices Market by Region, 2024-2034 (US$ Million, AGR %): “W” Shaped Recovery
Figure 9 Neuromodulation Devices Market by Region, 2024-2034 (US$ Million, AGR %): “L” Shaped Recovery
Figure 10 Neuromodulation Devices Market: Porter’s Five Forces Analysis
Figure 11 Neuromodulation Devices Market: PEST Analysis
Figure 12 Neuromodulation Devices Market by Product: Market Attractiveness Index
Figure 13 Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 14 Neuromodulation Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 15 Deep Brain Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 16 Deep Brain Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
Figure 17 Gastric Electric Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 18 Gastric Electric Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Spinal Cord Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 20 Spinal Cord Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Sacral Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 22 Sacral Nerve Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Vagus Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 24 Vagus Nerve Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Transcutaneous Electrical Nerve Stimulator Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 26 Transcutaneous Electrical Nerve Stimulator Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Others Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 28 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Neuromodulation Devices Market by Application: Market Attractiveness Index
Figure 30 Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 31 Neuromodulation Devices Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 32 Pain Management Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 33 Pain Management Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 34 Epilepsy Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 35 Epilepsy Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Essential Tremor Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 37 Essential Tremor Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Urinary and Fecal Incontinence Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 39 Urinary and Fecal Incontinence Market Share Forecast by Region, 2024 & 2034 (%)
Figure 40 Depression Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 41 Depression Market Share Forecast by Region, 2024 & 2034 (%)
Figure 42 Dystonia Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 43 Dystonia Market Share Forecast by Region, 2024 & 2034 (%)
Figure 44 Gastroparesis Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 45 Gastroparesis Market Share Forecast by Region, 2024 & 2034 (%)
Figure 46 Parkinson’s Disease Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 47 Parkinson’s Disease Market Share Forecast by Region, 2024 & 2034 (%)
Figure 48 Others Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
Figure 49 Others Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Neuromodulation Devices Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
Figure 51 Neuromodulation Devices Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 52 Neuromodulation Devices Market by Region, 2024-2034 (US$ Million, AGR %)
Figure 53 North America Neuromodulation Devices Market Attractiveness Index
Figure 54 North America Neuromodulation Devices Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 55 North America Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 56 North America Neuromodulation Devices Market Share Forecast by Country, 2024 & 2034 (%)
Figure 57 North America Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 58 North America Neuromodulation Devices Market Share Forecast by Product, 2024 & 2034 (%)
Figure 59 North America Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 60 North America Neuromodulation Devices Market Share Forecast by Application, 2024 & 2034 (%)
Figure 61 U.S. Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 62 Canada Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 63 Europe Neuromodulation Devices Market Attractiveness Index
Figure 64 Europe Neuromodulation Devices Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 65 Europe Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 66 Europe Neuromodulation Devices Market Share Forecast by Country, 2024 & 2034 (%)
Figure 67 Europe Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 68 Europe Neuromodulation Devices Market Share Forecast by Product, 2024 & 2034 (%)
Figure 69 Europe Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 70 Europe Neuromodulation Devices Market Share Forecast by Application, 2024 & 2034 (%)
Figure 71 Germany Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 72 France Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 73 UK Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 74 Italy Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 75 Spain Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 76 Russia Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 77 Rest of Europe Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 78 Asia Pacific Neuromodulation Devices Market Attractiveness Index
Figure 79 Asia Pacific Neuromodulation Devices Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 80 Asia Pacific Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 81 Asia Pacific Neuromodulation Devices Market Share Forecast by Country, 2024 & 2034 (%)
Figure 82 Asia Pacific Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 83 Asia Pacific Neuromodulation Devices Market Share Forecast by Product, 2024 & 2034 (%)
Figure 84 Asia Pacific Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 85 Asia Pacific Neuromodulation Devices Market Share Forecast by Application, 2024 & 2034 (%)
Figure 86 Japan Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 87 China Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 88 India Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 89 Australia Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 90 South Korea Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 91 Rest of Asia Pacific Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 92 Latin America Neuromodulation Devices Market Attractiveness Index
Figure 93 Latin America Neuromodulation Devices Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 94 Latin America Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 95 Latin America Neuromodulation Devices Market Share Forecast by Country, 2024 & 2034 (%)
Figure 96 Latin America Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 97 Latin America Neuromodulation Devices Market Share Forecast by Product, 2024 & 2034 (%)
Figure 98 Latin America Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 99 Latin America Neuromodulation Devices Market Share Forecast by Application, 2024 & 2034 (%)
Figure 100 Brazil Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 101 Mexico Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 102 Rest of Latin America Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 103 MEA Neuromodulation Devices Market Attractiveness Index
Figure 104 MEA Neuromodulation Devices Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 105 MEA Neuromodulation Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 106 MEA Neuromodulation Devices Market Share Forecast by Country, 2024 & 2034 (%)
Figure 107 MEA Neuromodulation Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 108 MEA Neuromodulation Devices Market Share Forecast by Product, 2024 & 2034 (%)
Figure 109 MEA Neuromodulation Devices Market Forecast by Application, 2024-2034 (US$ Million, AGR %)
Figure 110 MEA Neuromodulation Devices Market Share Forecast by Application, 2024 & 2034 (%)
Figure 111 GCC Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 112 South Africa Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 113 Rest of MEA Neuromodulation Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 114 Neuromodulation Devices Market: Company Share, 2022
Figure 115 Abbott: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 116 Abbott: R&D, 2017-2022 (US$ million, AGR%)
Figure 117 Abbott: Regional Market Shares, 2022
Figure 118 Boston Scientific Corporation.: Net Revenue, 2017-2022 (US$ million, AGR%)
Figure 119 Boston Scientific Corporation, Inc.: R&D, 2017-2022 (US$ million, AGR%)
Figure 120 Boston Scientific Corporation, Inc.: Regional Market Shares, 2022
Figure 121 electroCore, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 122 electroCore, Inc.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 123 electroCore, Inc.: Regional Market Shares, 2022
Figure 124 Helbling Holding AG: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 125 LivaNova PLC: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 126 LivaNova PLC: R&D, 2017-2022 (US$ Million, AGR%)
Figure 127 LivaNova PLC: Regional Market Shares, 2022
Figure 128 Medtronic: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 129 Medtronic: R&D, 2017-2022 (US$ Million, AGR%)
Figure 130 Medtronic: Regional Market Shares, 2022
Figure 131 Neuronetics, Inc: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 132 Neuronetics, Inc: R&D, 2017-2022 (US$ Million, AGR%)
Figure 133 Neuronetics, Inc: Regional Market Shares, 2022
List of Companies Profiled in the Report
Abbott
Boston Scientific Corporation
electroCore, Inc.
Helbling Holding AG
Innovative Health Solutions
LivaNova PLC
Medtronic
MicroTransponder Inc.
Neuronetics Inc.
Parasym
Synapse Biomedical Inc.
tVNS Technologies GmbH
List of Other Companies Mentioned in the Report
Actipulse Neuroscience
Affera, Inc.
Axonics, Inc.
Charco Neurotech Ltd.
Cognito Therapeutics
GrayMatters Health
Helius Medical Technologies, Inc.
Knight Therapeutics
Mainstay Medical Holdings plc
Medicrea
Motif Neurotech
Neuralink
Neuraxis Inc.
Obsidio, Inc
Otsuka Medical Devices Co., Ltd.
PathMaker Neurosystems
ShiraTronics, Inc
Theranica
United Medical Ltd.
Verily
List of Associations Mentioned in the Report
Canada’s National Population Health Study of Neurological Conditions
Case Western Reserve University
Centers for Disease Control and Prevention (CDC)
National Health Service (NHS)
Québec Ministry of Health and Social Services
U.S. Food and Drug Administration (FDA)
University of Oklahoma
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
